pubmed.ncbi.nlm.nih.gov

Endometriosis: alternative methods of medical treatment - PubMed

  • ️Thu Jan 01 2015

Endometriosis: alternative methods of medical treatment

Leticia Muñoz-Hernando et al. Int J Womens Health. 2015.

Abstract

Endometriosis is an inflammatory estrogen-dependent disease defined by the presence of endometrial glands and stroma at extrauterine sites. The main purpose of endometriosis management is alleviating pain associated to the disease. This can be achieved surgically or medically, although in most women a combination of both treatments is required. Long-term medical treatment is usually needed in most women. Unfortunately, in most cases, pain symptoms recur between 6 months and 12 months once treatment is stopped. The authors conducted a literature search for English original articles, related to new medical treatments of endometriosis in humans, including articles published in PubMed, Medline, and the Cochrane Library. Keywords included "endometriosis" matched with "medical treatment", "new treatment", "GnRH antagonists", "Aromatase inhibitors", "selective progesterone receptor modulators", "anti-TNF α", and "anti-angiogenic factors". Hormonal treatments currently available are effective in the relief of pain associated to endometriosis. Among new hormonal drugs, association to aromatase inhibitors could be effective in the treatment of women who do not respond to conventional therapies. GnRH antagonists are expected to be as effective as GnRH agonists, but with easier administration (oral). There is a need to find effective treatments that do not block the ovarian function. For this purpose, antiangiogenic factors could be important components of endometriosis therapy in the future. Upcoming researches and controlled clinical trials should focus on these drugs.

Keywords: GnRH antagonists; anti-TNF-α; antiangiogenic factors; aromatase inhibitors; endometrial tissue; hormonal treatments; pharmacological treatment options; selective progesterone receptor modulators.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389–2398. - PMC - PubMed
    1. Johnson NP, Hummelshoj L. Consensus on current management of endometriosis. Hum Reprod. 2013;28(6):1552–1568. - PubMed
    1. Streuli I, de Ziegler D, Santulli P. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother. 2013;14(3):291–305. - PubMed
    1. Allen C, Hopewell S, Prentice A, Gregory D. Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst Rev. 2009;2:CD004753. - PubMed
    1. Dunselman GA, Vermeulen N, Becker C, et al. European Society of Human Reproduction and Embryology ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014;29(3):400–412. - PubMed